These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21316292)

  • 1. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation.
    Williams AE; Arzola GM; Strutt AM; Simpson R; Jankovic J; York MK
    Parkinsonism Relat Disord; 2011 Jun; 17(5):321-7. PubMed ID: 21316292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.
    Kim HJ; Jeon BS; Paek SH; Lee KM; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Ehm G
    J Neurol; 2014 Jun; 261(6):1090-6. PubMed ID: 24687897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive change on the repeatable battery of neuropsychological status (RBANS) in Parkinson's disease with and without bilateral subthalamic nucleus deep brain stimulation surgery.
    Rinehardt E; Duff K; Schoenberg M; Mattingly M; Bharucha K; Scott J
    Clin Neuropsychol; 2010 Nov; 24(8):1339-54. PubMed ID: 20967688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial.
    Okun MS; Fernandez HH; Wu SS; Kirsch-Darrow L; Bowers D; Bova F; Suelter M; Jacobson CE; Wang X; Gordon CW; Zeilman P; Romrell J; Martin P; Ward H; Rodriguez RL; Foote KD
    Ann Neurol; 2009 May; 65(5):586-95. PubMed ID: 19288469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Boel JA; Odekerken VJ; Schmand BA; Geurtsen GJ; Cath DC; Figee M; van den Munckhof P; de Haan RJ; Schuurman PR; de Bie RM;
    Parkinsonism Relat Disord; 2016 Dec; 33():90-95. PubMed ID: 27688200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.
    Tramontana MG; Molinari AL; Konrad PE; Davis TL; Wylie SA; Neimat JS; May AT; Phibbs FT; Hedera P; Gill CE; Salomon RM; Wang L; Song Y; Charles D
    J Parkinsons Dis; 2015; 5(1):151-63. PubMed ID: 25613351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
    Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
    Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease.
    York MK; Dulay M; Macias A; Levin HS; Grossman R; Simpson R; Jankovic J
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):789-95. PubMed ID: 17965146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
    De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and Long-Term Cognitive Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease and Identification of Relevant Factors.
    Jahanshahi M; Leimbach F; Rawji V
    J Parkinsons Dis; 2022; 12(7):2191-2209. PubMed ID: 36155529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efforts of subthalamic nucleus deep brain stimulation on cognitive spectrum: From explicit to implicit changes in the patients with Parkinson's disease for 1 year.
    You Z; Wu YY; Wu R; Xu ZX; Wu X; Wang XP
    CNS Neurosci Ther; 2020 Sep; 26(9):972-980. PubMed ID: 32436660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus.
    Zahodne LB; Okun MS; Foote KD; Fernandez HH; Rodriguez RL; Wu SS; Kirsch-Darrow L; Jacobson CE; Rosado C; Bowers D
    J Neurol; 2009 Aug; 256(8):1321-9. PubMed ID: 19363633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.
    Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D;
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.
    Gruber D; Calmbach L; Kühn AA; Krause P; Kopp UA; Schneider GH; Kupsch A
    J Neural Transm (Vienna); 2019 Mar; 126(3):309-318. PubMed ID: 30684055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative cognitive burden as predictor of motor outcome following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Tang V; Zhu XL; Lau C; Chan A; Ma K; Yeung J; Cheung T; Abrigo J; Chan DYC; Chan D; Mok V; Poon WS
    Neurol Sci; 2022 Dec; 43(12):6803-6811. PubMed ID: 36048377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson's disease.
    Yamanaka T; Ishii F; Umemura A; Miyata M; Horiba M; Oka Y; Yamada K; Okita K; Matsukawa N; Ojika K
    Clin Neurol Neurosurg; 2012 May; 114(4):347-51. PubMed ID: 22176916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Marshall DF; Strutt AM; Williams AE; Simpson RK; Jankovic J; York MK
    Eur J Neurol; 2012 Dec; 19(12):1525-31. PubMed ID: 22632922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson's Disease: A Meta-Analysis.
    Combs HL; Folley BS; Berry DT; Segerstrom SC; Han DY; Anderson-Mooney AJ; Walls BD; van Horne C
    Neuropsychol Rev; 2015 Dec; 25(4):439-54. PubMed ID: 26459361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.